More women with breast cancer will be switched from tamoxifen to one of the aromatase inhibitors

April 2004

More women with breast cancer will be switched from tamoxifen to one of the aromatase inhibitors... Arimidex, Femara, or Aromasin.

These drugs seem more effective for preventing recurrence in postmenopausal women with estrogen-receptor positive breast cancer.

Tamoxifen blocks estrogen receptors...but tumors can become resistant to its effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote